Rare Case of Fungal Endocarditis of the Right Heart
Published: 2023-04-20
Page: 14-17
Issue: 2023 - Volume 5 [Issue 1]
Meriem El-Mousaid *
Service de Cardiologie, CHU Ibn Rochd, Casablanca, Morocco.
Asmaa Elamraoui
Service de Cardiologie, CHU Ibn Rochd, Casablanca, Morocco.
Dounia Bennani
Service de Cardiologie, CHU Ibn Rochd, Casablanca, Morocco.
Fadoul Adam Fadoul
Service de Cardiologie, CHU Ibn Rochd, Casablanca, Morocco.
Fadwa Essadqi
Service de Cardiologie, CHU Ibn Rochd, Casablanca, Morocco.
Drighil Abdennaser
Service de Cardiologie, CHU Ibn Rochd, Casablanca, Morocco.
Rachida Habbal
Service de Cardiologie, CHU Ibn Rochd, Casablanca, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Fungal endocarditis of the right heart constitutes a pathological entity of often delicate diagnosis, associated with a potentially severe prognosis. We report the case of a 37-year-old patient, hospitalized for Candida albicans infective endocarditis of the right heart on a tunneled hemodialysis KT, in whom the clinical history, the means of exploration as well as the therapy deployed are described.
Keywords: Fungal endocarditis, right heart, Candida albicans, hemodialysis
How to Cite
Downloads
References
Cooper HL, Brady JE, Ciccarone D, Tempalski B, Gostnell K, Friedman SR. National increase in the number of hospitalizations for infective endocarditis related to illicit injection drug use. Clin Infect Dis. 2017;45:1200-3.
Gebo KA, Burkey MD, Lucas GM, Moore RD, Wilson LE. Incidence, risk factors for clinical presentation, and one-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr. 2016;43:426-32.
Carozza A, De Santo LS, Romano G, Della CA, Ursomando F, Scardone M, et al. Infectious endocarditis in intravenous drug abusers: presentation patterns and long-term results of surgical treatment. J Heart Valve Dis. 2016;15:125-31.
Miro JM, del Rio A, Mestres CA. Infectious endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected persons.
Saydain G, Singh J, Dalal B, Yoo W, Levine DP. Outcome of patients with endocarditis associated with injection drug use admitted to an intensive care unit. J Crit Care. 2010;25:248-53.
Sousa C, Botelho C, Rodrigues D, Azeredo J, Oliveira R. Infective endocarditis in intravenous drug abusers: an update. Eur J Clin Micro.
San Roman JA, Vilacosta I, Lopez J, Revilla A, Arnold R, Sevilla T, et al. Role of transthoracic and transesophageal echocardiography in right-sided endocarditis: One echocardiographic modality does not fit all. J Am Soc Echocardiogr. 2012;25:807-14.
Gaca JG, Sheng S, Daneshmand M, Rankin JS, Williams ML, O'Brien SM, et al. Current outcomes for infective tricuspid valve endocarditis surgery in North America. Ann Thorac Surg. 2013;96: 1374-81.
Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents. 2016;27:359-66.
Leroy OGJ, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, et al. Epidemiology, management and risk factors for death from invasive Candida infections in intensive care: a multicentre, prospective and observational study in France (2015-2016). Crit Care Med. 2017, revised.
Regnier BAM, Bezie Y, Blanc V, Buzyn A, Choutet P, Mimoz O, et al. Management of invasive aspergillosis and candidiasis in adults. SFAR, SPILF, SRLF joint consensus conference. Ann Fr Anesth Reanim. 2014;5-13 [special issue].
Pappas PG, Kauffman CA, Andes D, Benjamin Jr DK, Calandra TF, Edwards J, et al. Clinical practice guidelines for the management of candidiasis: 2019 update from the Infectious Diseases Society of America. Clin Infect Dis. 2019;48: 503-35.
Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, Alvarez M, et al. Long- term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS. 2016;20: 2183-91.
Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, et al. Comparison of epidemiological, clinical and biological characteristics of invasive aspergillosis in neutropenic and non-neutropenic patients: a 6-year survey. Clin Infect Dis. 2016;43:577-84.
Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for the primary treatment of invasive aspergillosis. N Engl J Med. 2012;347: 408-15.
Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, et al. A randomized, blinded, multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as a treatment for candidemia and its consequences in non-neutropenic subjects. Clin Infect Dis. 2013;36:1221-8.